Optimize drug therapy and monitor patient adherence.
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
New York DOH Approval Status
Timing of specimen collection: Pre-dose (trough) draw - At steady state concentration.
Plain red. Also acceptable: Lavender (K2 or K3EDTA) or pink (K2EDTA ).
Separate serum or plasma from cells within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Whole blood. Gel separator tubes, light blue (citrate), or yellow (SPS or ACD solution).
After separation from cells: Ambient: 12 hours; Refrigerated: 1 week; Frozen: 1 week
Effective February 18, 2014
|Therapeutic Range:||0.5-2.5 µg/mL|
|Toxic:||Greater than 4 µg/mL|
Adverse effects may include sedation, fatigue, headache, blurred vision and nausea.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
80338 (Alt code: G0480)
|Component Test Code*||Component Chart Name||LOINC|
- desyrel blood level
- trazodone blood level